Life after radical prostatectomy: recovery, function, and PSA follow-up

Leave the hospital with an owned recovery plan

The surgical team should explain catheter care, activity limits, pain management, bowel care, incision care, and the date for the next visit. Instructions vary with the procedure and the patient’s health. A generic recovery timeline should not replace the surgeon’s instructions.

Ask who to call for fever, worsening pain, heavy bleeding or clots, inability of the catheter to drain, shortness of breath, new leg swelling, vomiting, or another concerning change. A portal message may not be the right route for an urgent problem.

Pelvic-floor instruction may begin before surgery so the patient can identify the correct muscles, then resume after surgery when the surgical team says it is safe. The plan should state whether exercises pause while the catheter is in place and when supervised pelvic-floor physical therapy is appropriate.

Urinary control can change after surgery

Leakage is common after radical prostatectomy, but the amount and recovery pattern vary. The care team may recommend pelvic-floor exercises and should explain how to perform them correctly. More is not always better; pain, poor technique, or overuse can make a self-directed plan unhelpful.

Track pads, leakage patterns, urgency, nighttime symptoms, and changes over time. If recovery is not following the expected course, ask when pelvic-floor physical therapy, medication review, testing, or another treatment should be considered.

Urine leakage with orgasm (climacturia) or arousal can occur and may be difficult to raise in a visit. It belongs in the continence and sexual-recovery discussion rather than being dismissed. Persistent bothersome leakage has evaluation and treatment options that depend on the pattern and time from surgery.

Sexual and reproductive effects need direct counseling

Erectile function can change after prostate surgery. Baseline function, age, other health conditions, the operation, cancer location, nerve-sparing feasibility, and recovery all matter. Ask before surgery what outcomes are realistic and after surgery when rehabilitation options can be discussed.

Clinician-guided rehabilitation may include a PDE5 inhibitor, a vacuum erection device, urethral or penile-injection therapy, counseling, and—when recovery remains inadequate and the patient wants it—a penile prosthesis discussion. These are not a universal sequence or dosing plan. Nitrates and other health factors can make some options unsafe.

Some patients report perceived penile shortening after radical prostatectomy. Measurement, expectations, tissue health, weight change, and erectile recovery can affect that experience. A public page should acknowledge the concern without promising that one rehabilitation method prevents it.

Radical prostatectomy also affects ejaculation and fertility. People who may want biological children should ask about fertility preservation before treatment. These issues deserve direct counseling and should not be reduced to a single recovery statistic.

PSA after radical prostatectomy is not interpreted like screening PSA

PSA is used to monitor after surgery for prostate cancer. The responsible clinician should explain when the first postoperative test is planned, which laboratory will be used, what assay sensitivity means, and how results will be communicated.

A detectable or rising result needs context. One value, a small fluctuation, or a screening reference range should not be used alone to decide that cancer has returned or that another treatment must start. The pathology report, PSA pattern, time from surgery, imaging, overall risk, and the potential benefit and timing of additional treatment may all matter.

Do not compare a postoperative result with an age-based screening chart. Bring every result with its date and laboratory, and ask whether a repeat test is needed before a decision.

Recovery milestones need owners, not generic deadlines

Recovery speed varies with the operation, surgical findings, baseline health, complications, and the surgeon's protocol. Use milestones to close handoffs, not to self-clear an activity or decide that recovery is late.

The milestone names are broadly useful; the timing is individual. The surgeon's written instructions override a generic web timeline, and a new concerning symptom should follow the urgent-contact plan rather than waiting for the next milestone.

### Understand the biochemical-recurrence threshold

The current AUA/ASTRO/SUO salvage guideline defines biochemical recurrence after radical prostatectomy as PSA at or above 0.2 ng/mL. It also recognizes that selected high-risk patients may discuss early salvage radiation below 0.2 ng/mL and that a rising ultrasensitive PSA trend should be confirmed before therapy when the formal definition is not met. These are related but separate concepts; the responsible clinician should interpret the individual pattern.

When salvage radiation is discussed, the decision may include the PSA trend and doubling time, pathologic Grade Group, margin and stage findings, imaging such as PSMA PET when appropriate, life expectancy, prior treatment, and whether androgen-deprivation therapy is part of the plan.

Read the pathology report as a decision document

The follow-up visit should connect the final pathology with the surveillance plan. Ask about Grade Group, pathologic T stage, extraprostatic extension, seminal-vesicle invasion, surgical margins and their location/extent, lymph nodes when sampled, and any other finding that changes monitoring or treatment discussions. “No further treatment now” should still include an exact PSA schedule and escalation trigger.